Answers
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > Look Familiar?

Tags

  • victim
  • through
  • number
  • developing combination
  • developing combination
  • shares usually

  • Links

  • Ethical Search Engine Optimization Meets The Consistent Value Proposition
  • The Pros And Cons Of Outsourcing Marketing Function For Small Business Owners
  • How To Cure Premature Ejaculation
  • Answers - Look Familiar?

    Don't I Know You From Somewhere?

    If any of the following situations look familiar to you, you may want to consider our quick fix. For every situation, there is an appropriate response that can
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    maximize your benefit, and limit your loss. Take a look at some of these for example.

    Holding A Dog

    Your stock continues to sink, week by week. You keep thinking that it can't go any lower,
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    r that it will rebound eventually. Volume dries up, the price flat-lines... Rumors of reverse splits materialize. The stock is below minimum listing requirements for its parent exchange.

    Diagn
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    sis: You are probably holding a sinking ship. You may think it can't go lower, but it can. It can go to zero. Usually after a reverse-split the price continues to decline. If shares are bumped
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    rom their exchange two things will happen: the price will take an immediate hit, and trading volumes will dry up so it will be harder to sell shares. Usually in these situations it is better to
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    admit you made a mistake and get what capital you have left out of the investment.

    Worm-Tongue

    Your associate tells you about a penny stock that is going to make a serious move. They've got a
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    patented technology that sounds flashy, although even after he explains it neither of you really understand what it does or how it works. It is going to set a new standard in the industry, and
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    he potential market for their sales is in the billions. His tip comes from an 'inside' guy at the company. He doesn't know the official title of the inside guy, and he can't tell you the compan
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    's revenues, employee size, management structure, or how long they've been in business.

    Diagnosis: Your associate may be the victim of a 'promotional' stock. Be careful! It's catchy. You are a
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    out to become the next victim in the line, and you'll probably infect a few others too. And when they tell the story of this miraculously undiscovered penny stock, they'll be saying this news a
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    l comes from an 'inside guy' at the company. Almost always these situations turn out badly. Things are not as they seem. You aren't taking a gamble on a stock with some potential. You are one o
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    f a hundred targets in a carefully constructed and well-planned promotional scheme to drive the share price up. These schemes are immoral, illegal, and... they happen all the time.

    Message In
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    Bottle

    You read a detrimental comment in a chat room or message board about a stock you hold or are thinking of buying. It scares you and makes you second guess your investment decisions. You
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    see that other people have responded in agreement to the posted message.

    Diagnosis: Maybe there is some truth to it, maybe none whatsoever. Check with some official sources to confirm or deny
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    he comments. Look at the latest press releases if it is a factual matter. Call the Investor Relations department if it is a theoretical or rumor-based matter. Consider all message board and cha
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    room information dishonest until proven honest.

    Shooting The Moon

    Your stock has been soaring, and your profits are significant, although you still haven't sold your shares. You like the com
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    any and had intended to invest for the long-term, although you hadn't expected such strong performance. If the stock has spiked this high, it's value must be getting recognized, so it could pro
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ably go higher.

    Diagnosis: The stock may be ready for a short term pull back. Profit-taking sales are inevitable, and each time the shares go a little higher the number of people thinking abou
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    taking their money out increases. After a strong run-up shares usually suffer some weakness, and if the rise was based on a press release or rumor that won't significantly impact the company's
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ability to meet their goals, shares may be prone to coming all the way back down to their previous level. You may want to sell half of your holdings to lock in your gains, and let the rest ride


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.answers.org.ua/article/104349/answers-Look-Familiar.html">Look Familiar?</a>

    BB link (for phorums):
    [url=http://www.answers.org.ua/article/104349/answers-Look-Familiar.html]Look Familiar?[/url]

    Related Articles:

    Do You Know the Rules?

    Portable Trade Show Displays

    10 Step-by-Step Business Startup Guide- Step 5

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com